Adjunct Faculty, Department of Biotechnology and Chemical Engineering
Dr. Neha Sureshchandra Gandhi
Adjunct Faculty (Professor), Department of Biotechnology and Chemical
Engineering
Manipal University Jaipur
Qualification:
- PhD Curtin University, Australia 2012
- Mphil Curtin University, Australia 2008
- B.E. The Maharaja Sayirao University of Baroda 2000
Area of expertise
- Computational chemistry and biophysics
- Proteins and peptides
- Computational glycobiology
- Computer aided drug design
Achievements
- Built a high-impact research profile in computational molecular sciences with 81 peer-reviewed papers, 4200+ citations, and a Google Scholar h-index of 32
- Awarded grants over $8 million
- Recognised for research excellence, including QUT Faculty of Science Mid-Career Researcher of the Year (2021) and other publication awards
- Led major capability and program building, including serving as MSc Program Coordinator (Computational Molecular Sciences, MAHE; starting July 2025) and coordinated high-performance computing infrastructure development at MAHE with industry/government partners (2024–25).
Responsibility
- Foster collaboration between academia and industry – Engage with industry partners to promote joint research, internships, and knowledge exchange.
- Teach advanced topics/courses in the area of expertise – Deliver lectures and seminars on specialized subjects to enhance student learning.
- Develop advanced courses and syllabi – Design and update curriculum in line with current academic and industry trends.
- Supervise B.Tech./M.Tech./Ph.D. students and support placement efforts – Guide students in research and project work while contributing to their career development through placement support.
- Publish research papers with MUJ affiliation – Contribute to the academic reputation of MUJ through high-quality publications in reputed journals.
Responsibility at Department Level
- Review curriculum, apply for research centers/grants with MUJ faculties
Publications
- C. J. Mycroft-West, D. Su, I. Pagani, T. R. Rudd, S. Elli, N. S. Gandhi, et al., “Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin,” Thrombosis and Haemostasis, vol. 120, no. 12, pp. 1700–1715, Dec. 2020, doi: 10.1055/s-0040-1721319
- The Atomwise AIMS Program, I. Wallach, D. Bernard, K. Nguyen, et al., “AI is a viable alternative to high throughput screening: a 318-target study,” Scientific Reports, vol. 14, no. 1, Art. no. 7526, Apr. 2024, doi: 10.1038/s41598-024-54655-z.
- S. I. Hossain, N. S. Gandhi, Z. E. Hughes, and S. C. Saha, “Computational Modelling of the Interaction of Gold Nanoparticle with Lung Surfactant Monolayer,” MRS Advances, vol. 4, no. 20, pp. 1177–1185, 2019, doi: 10.1557/adv.2019.93.
- S. E. Guimond, C. J. Mycroft-West, N. S. Gandhi, et al., “Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction,” ACS Central Science, vol. 8, no. 5, pp. 527–545, 2022, doi: 10.1021/acscentsci.1c01293.
- E. D. Boittier, Y. Y. Tang, M. E. Buckley, Z. P. Schuurs, D. J. Richard, and N. S. Gandhi, “Assessing Molecular Docking Tools to Guide Targeted Drug Discovery of CD38 Inhibitors,” International Journal of Molecular Sciences, vol. 21, no. 15, Art. no. 5183, Jul. 2020, doi: 10.3390/ijms21155183.
Contact Details:
